Sponsored Helpline
Our Blog
Podcast: Substance Use Disorders Raise Anxiety Risk, and Recovery Changes the Odds
New research finds that people with cannabis, alcohol, or nicotine use disorders face a substantially elevated risk of developing generalized anxiety disorder within a decade, and remission cuts that...
Written By: Dr. Sylvie Stacy
November 3, 2026
Weight Loss Drug May Raise Lithium Risk for Psychiatric Patients
Written By: Peter Lee
November 3, 2026
Mindfulness Therapy Shows Promise for Reducing Opioid Cravings
Written By: Eric Owens
November 2, 2026
Substance Misuse May Be Tied to Rising Strokes in Younger Adults
Written By: Quentin Blount
October 28, 2026
Cannabis Use Disorder in Pregnancy Tied to Postpartum Crisis Risk
Written By: Terri Beth Miller
October 28, 2026
All Posts
Podcast: How Addiction Rewires the Brain at Every Age
This week’s episode covers three studies that map how addiction changes the...
Continue Reading
Brown Researchers Link Hunger to Alcohol Reward Memories in Study
New research on the biology of craving could eventually inform addiction...
Continue Reading
US Nonresidential Opioid Care Claims Up 389 Percent Since 2022
New insurance claims data give treatment seekers and providers a closer view of...
Continue Reading
New Science Is Expanding Addiction Treatment Options
The science behind addiction treatment is advancing faster than the treatment...
Continue Reading
Art Therapy Programs Reduce Depression and Anxiety in Youth
The arts have been used in recent decades to complement more traditional...
Continue Reading
Binge Eating May Affect Teen Mental Health, CDC Finds
For the first time, the CDC has a national number for a behavior that has lived...
Continue Reading
Addiction Treatment Study Ties Substance Use to Anxiety Risk
People researching rehab often focus on one condition at a time, but new...
Continue Reading
Study Maps White Matter Changes Across Drug Addiction Types
Addiction changes the brain in different ways depending on the substance. A...
Continue Reading
CVS Agrees to Pay $315 Million to Settle Opioid Prescription Case
CVS Pharmacy and its subsidiaries have agreed to pay $315 million to resolve a...
Continue Reading